posted on 2020-08-20, 04:11authored byJeanette Dawa, Gideon O. Emukule, Edwine Barasa, Marc Alain Widdowson, Omu Anzala, Edwin van Leeuwen, Marc Baguelin, Sandra S. Chaves, Rosalind M. Eggo
Additional file 3. Additional tables showing: average number of influenza associated disease states and DALYs with their 95% credible interval limits, (2010–2018) (table on sheet 1); average annual rate per 100,000 of influenza associated disease states with their 95% credible interval limits, (2010–2018) (table on sheet 2); average number of influenza associated health care utilisation events with their 95% credible interval limits, (2010–2018) (table on sheet 3); national cost of influenza associated illness across all ages, (2010–2018) (table on sheet 4); average annual costs and 95% credible intervals (CIs) per vaccination strategy in millions of USD (table on sheet 5); incremental cost-effectiveness ratio for influenza vaccination using total societal costs (table on sheet 6).
Funding
Carnegie Corporation of New York Sida DELTAS Africa Initiative Deutscher Akademischer Austauschdienst (DAAD) Tropical Diseases Modelling (TDMOD) network National Institute for Health Research HDR UK Innovation Fellowship